Whole Blood Genomic Biomarkers of Acute Cardiac Allograft Rejection

Journal of Heart and Lung Transplantation

Volumn 28, Issue 9, 2009, Pages 927-935

  Lin, David ^a   Hollander, Zsuzsanna ^a   Ng, Raymond T ^a   Imai, Carol ^a   Ignaszewski, Andrew ^a   Balshaw, Robert ^a   Freue, Gabriela Cohen ^a   Wilson McManus, Janet E ^a   Qasimi, Pooran ^a   Meredith, Anna ^a   Mui, Alice ^a   Triche, Tim ^a   McMaster, Robert ^a   Keown, Paul A ^a   McManus, Bruce M ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RNA; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD SAMPLING; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GENE EXPRESSION; GENOMICS; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONGITUDINAL STUDY; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; CYCLOSPORINE; FEMALE; GENETIC MARKERS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA; TACROLIMUS;

EID: 68949204945     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.04.025     Document Type: Article

References (75)

1. McManus C.A., Rose M.L., and Dunn M.J. Proteomics of transplant rejection. Transplant Rev 20 (2006) 195-207
2. Mehra M.R., Feller E., and Rosenberg S. The promise of protein-based and gene-based clinical markers in heart transplantation: from bench to bedside. Nat Clin Pract Cardiovasc Med 3 (2006) 136-143
3. Wong B.W., Rahmani M., Rezai N., and McManus B.M. Progress in heart transplantation. Cardiovasc Pathol 14 (2005) 176-180
4. Starling R.C., Pham M., Valantine H., et al. Molecular testing in the management of cardiac transplant recipients: initial clinical experience. J Heart Lung Transplant 25 (2006) 1389-1395
5. Evans R.W., Williams G.E., Baron H.M., et al. The economic implications of noninvasive molecular testing for cardiac allograft rejection. Am J Transplant 5 (2005) 1553-1558
6. Mehra M.R. Contemporary concepts in prevention and treatment of cardiac allograft vasculopathy. Am J Transplant 6 (2006) 1248-1256
7. Baxter-Lowe L.A., and Busch M.P. Tracking microchimeric DNA in plasma to diagnose and manage organ transplant rejection. Clin Chem 52 (2006) 559-561
8. Deng M.C., Eisen H.J., Mehra M.R., et al. Noninvasive discrimination of rejection in cardiacallograft recipients using gene expression profiling. Am J Transplant 6 (2006) 150-160
9. Mehra M.R. The emergence of genomic and proteomic biomarkers in heart transplantation. J Heart Lung Transplant 24 (2005) S213-S218
10. Alpert S., Lewis N.P., Ross H., Fowler M., and Valantine H.A. The relationship of granzyme A and perforin expression to cardiac allograft rejection and dysfunction. Transplantation 60 (1995) 1478-1485
11. Bernstein D., Williams G.E., Eisen H., et al. Gene expression profiling distinguishes a molecular signature for grade 1B mild acute cellular rejection in cardiac allograft recipients. J Heart Lung Transplant 26 (2007) 1270-1280
12. Baan C.C., van Emmerik N.E., Balk A.H., et al. Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplants. Clin Exp Immunol 97 (1994) 293-298
13. de Groot-Kruseman H.A., Baan C.C., Hagman E.M., et al. Intragraft interleukin 2 mRNA expression during acute cellular rejection and left ventricular total wall thickness after heart transplantation. Heart 87 (2002) 363-367
14. Horwitz P.A., Tsai E.J., Putt M.E., et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 110 (2004) 3815-3821
15. Shulzhenko N., Morgun A., Franco M., et al. Expression of CD40 ligand, interferon- gamma and Fas ligand genes in endomyocardial biopsies of human cardiac allografts: correlation with acute rejection. Braz J Med Biol Res 34 (2001) 779-784
16. Shulzhenko N., Morgun A., Rampim G.F., et al. Monitoring of intragraft and peripheral blood TIRC7 expression as a diagnostic tool for acute cardiac rejection in humans. Hum Immunol 62 (2001) 342-347
17. Shulzhenko N., Morgun A., Zheng X.X., et al. Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation. Transplantation 72 (2001) 1705-1708
18. van Emmerik N., Baan C., Vaessen L., et al. Cytokine gene expression profiles in human endomyocardial biopsy (EMB) derived lymphocyte cultures and in EMB tissue. Transpl Int 7 Suppl 1 (1994) S623-S626
19. Schoels M., Dengler T.J., Richter R., Meuer S.C., and Giese T. Detection of cardiac allograft rejection by real-time PCR analysis of circulating mononuclear cells. Clin Transplant 18 (2004) 513-517
20. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
21. Bolstad B. Low level analysis of high-density oligonucleotide array data: Background, normalization and summarization (2004), University of California, Berkeley
22. Irizarry R., Hobbs B., Collin F., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 (2003) 249-264
23. Cohen Freue G.V., Hollander Z., Shen E., et al. MDQC: a new quality assessment method for microarrays based on quality control reports. Bioinformatics 23 (2007) 3162-3169
24. SAS. http://www.sas.com/
25. The R Project for Statistical Computing. http://www.r-project.org/
26. Gentleman R., Carey V., Bates D., et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biology 5 (2004) R80
27. Bolstad B., Irizarry R., Astrand M., and Speed T. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 (2003) 185-193
28. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 (2001) 5116-5121
29. Limma S.G. linear models for microarray data. In: Gentleman R., Carey V., Dudoit S., and Irizarry R. (Eds). Bioinformatics and Computational Biology Solutions using R and Bioconductor (2005), Springer, New York W H
30. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3 (2004) Article3
31. Al-Shahrour F., Minguez P., Tarraga J., et al. FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments. Nucleic Acids Res 35 (2007) W91-W96
32. Al-Shahrour F., Minguez P., Tarraga J., et al. BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments. Nucleic Acids Res 34 (2006) W472-W476
33. Moll S., and Pascual M. Humoral rejection of organ allografts. Am J Transplant 5 (2005) 2611-2618
34. Land W.G. Innate immunity-mediated allograft rejection and strategies to prevent it. Transplant Proc 39 (2007) 667-672
35. Morey J.S., Ryan J.C., and Van Dolah F.M. Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced Online 8 (2006) 175-193
36. Etienne W., Meyer M.H., Peppers J., and Meyer Jr. R.A. Comparison of mRNA gene expression by RT-PCR and DNA microarray. Biotechniques 36 (2004) 618-620 22, 24-6
37. Barth A.S., and Hare J.M. The potential for the transcriptome to serve as a clinical biomarker for cardiovascular diseases. Circ Res 98 (2006) 1459-1461
38. Bonassi S., Neri M., and Puntoni R. Validation of biomarkers as early predictors of disease. Mutat Res 480-481 (2001) 349-358
39. Waheed A., Britton R.S., Grubb J.H., Sly W.S., and Fleming R.E. HFE association with transferrin receptor 2 increases cellular uptake of transferrin-bound iron. Arch Biochem Biophys 474 (2008) 193-197
40. Pugh C., Hathwar V., Richards J.H., Stonehuerner J., and Ghio A.J. Disruption of iron homeostasis in the lungs of transplant patients. J Heart Lung Transplant 24 (2005) 1821-1827
41. Artac H., Coskun M., Karadogan I., Yegin O., and Yesilipek A. Transferrin receptor in proliferation of T lymphocytes in infants with iron deficiency. Int J Lab Hematol 29 (2007) 310-315
42. Kharas M.G., Yusuf I., Scarfone V.M., et al. KLF4 suppresses transformation of pre-B cells by ABL oncogenes. Blood 109 (2007) 747-755
43. Yusuf I., Kharas M.G., Chen J., et al. KLF4 is a FOXO target gene that suppresses B cell proliferation. Int Immunol 20 (2008) 671-681
44. Voskoboinik I., Smyth M.J., and Trapani J.A. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 6 (2006) 940-952
45. Waterhouse N.J., Sedelies K.A., Browne K.A., et al. A central role for Bid in granzyme B- induced apoptosis. J Biol Chem 280 (2005) 4476-4482
46. Kim B.M., and Chung H.W. Hypoxia/reoxygenation induces apoptosis through a ROS- mediated caspase-8/Bid/Bax pathway in human lymphocytes. Biochem Biophys Res Commun 363 (2007) 745-750
47. Arbuzova A., Schmitz A.A., and Vergeres G. Cross-talk unfolded: MARCKS proteins. Biochem J 362 (2002) 1-12
48. Aderem A. The MARCKS brothers: a family of protein kinase C substrates. Cell 71 (1992) 713-716
49. Allen L.H., and Aderem A. A role for MARCKS, the alpha isozyme of protein kinase C and myosin I in zymosan phagocytosis by macrophages. J Exp Med 182 (1995) 829-840
50. Blackshear P.J. The MARCKS family of cellular protein kinase C substrates. J Biol Chem 268 (1993) 1501-1504
51. Ding Y., Kantarci A., Badwey J.A., Hasturk H., Malabanan A., and Van Dyke T.E. Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by mononuclear phagocytes in diabetes mellitus. J Immunol 179 (2007) 647-654
52. Liscovitch M., and Cantley L.C. Lipid second messengers. Cell 77 (1994) 329-334
53. Newton A.C., and Johnson J.E. Protein kinase C: a paradigm for regulation of protein function by two membrane-targeting modules. Biochim Biophys Acta 1376 (1998) 155-172
54. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334 (1988) 661-665
55. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258 (1992) 607-614
56. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9 (1995) 484-496
57. Zhao Y., Neltner B.S., and Davis H.W. Role of MARCKS in regulating endothelial cell proliferation. Am J Physiol Cell Physiol 279 (2000) C1611-C1620
58. Zhou W., Peng Q., Li K., and Sacks S.H. Role of dendritic cell synthesis of complement in the allospecific T cell response. Mol Immunol 44 (2007) 57-63
59. Hamann J., Montgomery K.T., Lau S., Kucherlapati R., and van Lier R.A. AICL: a new activation- induced antigen encoded by the human NK gene complex. Immunogenetics 45 (1997) 295-300
60. Welte S., Kuttruff S., Waldhauer I., and Steinle A. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat Immunol 7 (2006) 1334-1342
61. Fildes J.E., Yonan N., and Leonard C.T. Natural killer cells and lung transplantation, roles in rejection, infection, and tolerance. Transpl Immunol 19 (2008) 1-11
62. Birukova A.A., Malyukova I., Mikaelyan A., Fu P., and Birukov K.G. Tiam1 and betaPIX mediate Rac-dependent endothelial barrier protective response to oxidized phospholipids. J Cell Physiol 211 (2007) 608-617
63. Mzali R., Seguin L., Liot C., et al. Regulation of Rho signaling pathways in interleukin-2- stimulated human T-lymphocytes. FASEB J 19 (2005) 1911-1913
64. Ando A., and Suzuki C. Cooperative function of the CHD5-like protein Mdm39p with a P-type ATPase Spf1p in the maintenance of ER homeostasis in Saccharomyces cerevisiae. Mol Genet Genomics 273 (2005) 497-506
65. Antonarakis S.E. 10 years of Genomics, chromosome 21, and Down syndrome. Genomics 51 (1998) 1-16
66. Wang Q., Zhu X., Xu Q., Ding X., Chen Y.E., and Song Q. Effect of C-reactive protein on gene expression in vascular endothelial cells. Am J Physiol Heart Circ Physiol 288 (2005) H1539-H1545
67. Chase A., Grand F.H., and Cross N.C. Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome. Blood 110 (2007) 3729-3734
68. Grand E.K., Grand F.H., Chase A.J., et al. Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer 40 (2004) 78-83
69. Bellacosa A., Cicchillitti L., Schepis F., et al. MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc Natl Acad Sci U S A 96 (1999) 3969-3974
70. Turner D.P., Cortellino S., Schupp J.E., et al. The DNA N-glycosylase MED1 exhibits preference for halogenated pyrimidines and is involved in the cytotoxicity of 5-iododeoxyuridine. Cancer Res 66 (2006) 7686-7693
71. Parsons B.L. MED1: a central molecule for maintenance of genome integrity and response to DNA damage. Proc Natl Acad Sci U S A 100 (2003) 14601-14602
72. Bader S., Walker M., Hendrich B., et al. Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene 18 (1999) 8044-8047
73. Cortellino S., Turner D., Masciullo V., et al. The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. Proc Natl Acad Sci U S A 100 (2003) 15071-15076
74. Riccio A., Aaltonen L.A., Godwin A.K., et al. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet 23 (1999) 266-268
75. Kfoury A.G., Stehlik J., Renlund D.G., et al. Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns. J Heart Lung Transplant 25 (2006) 1277-1282